LDLR and familial hypercholesterolemia: As an example, Cayo et al. (119) performed a drug screen on iHeps generated from iPSCs carrying a mutation in LDLR (isolated from a familial hypercholesterolemia patient) to identify potential compounds to treat hypercholesterolemia.